A single systemic injection of AAV9-hIGFBP2 prevents left ventricular hypertrophy and dysfunction in metabolic syndrome

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Basic science - Gene and cell therapy - Cytokines and inflammation - Molecular biology - Genetics Gene and cell therapy HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

ESC 365 is supported by

ESC 365 is supported by